Product Information

DEXTROAMP-AMPHETAM 12.5 MG TAB is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.5223 per EA under NDC 70010011401. Its NADAC has been published 14 times since Aug 9, 2023.

FDA first approved this application on Dec 28, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has been published 14 times since Aug 9, 2023, and over the history we have for it it has declined 14.7%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.